Medisca Texas Facility Receives Perfect Score in 2018 FDA GMP Inspection

“As a company, MEDISCA puts patient safety first. To do that, we prioritize quality products and systems that allow us to eliminate risk to patient health,” said Antonio Dos Santos, President of MEDISCA. “Achieving a perfect score on our recent cGMP inspection is an example of our dedication to rigorous testing and management processes that ultimately impact the quality of life of the millions of patients who rely on customized medicine.”

In 2014, MEDISCA implemented MasterControl, a robust Quality Management System allowing standardization of documentation, systems and processes across the company as it continues to expand globally. MEDISCA applies both validated electronic systems as well as physical segregation of material within its facilities to ensure quarantined, rejected, returned or recalled material is held in quarantine status until authorized personnel is able to determine whether there’s a risk to patients. Beyond MEDISCA’s rigorous facility requirements, the company also requires its manufacturers to be FDA registered and subject to regulatory inspections; requires evidence that the manufacturer produces APIs according to GMP; enforces a quality agreement to be signed; ensures APIs meet the latest pharmacopoeia; and reviews stability studies to validate all manufacturers’ expiration dates.

For more information on MEDISCA, please visit www.medisca.com.

About MEDISCA

MEDISCA is the leader in providing turnkey solutions to the pharmaceutical compounding industry and allied health care professionals worldwide. Through its global partners, LP3 Network and MEDISCA Network, MEDISCA is committed to being a complete resource for prescribers, pharmacists and pharmacy technicians engaged in personalized medicine by offering educational trainings, products, and support. Founded in 1989, the company has locations in Canada, the United States and Australia, optimizing its service to the international market. For more information about MEDISCA, please visit www.medisca.com and follow us on Twitter at @medisca.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181207005389/en/